Gene expression profile related to prognosis of acute myeloid leukemia

Oncology Reports

Volumn 18, Issue 6, 2007, Pages 1395-1402

  Park, Min Ha ^a   Cho, Sun A ^a   Yoo, Kyung Hyun ^a   Yang, Moon Hee ^a   Ahn, Ji Young ^b   Lee, Hyo Soo ^a   Lee, Kyoung Eun ^b   Mun, Yeung Chul ^b   Cho, Dae Ho ^a   Seong, Chu Myong ^b   Park, Jong Hoon ^a  

^a Sookmyung Women's University   (South Korea)

^b Ewha Womans University   (South Korea)

Author keywords

Acute myeloid leukemia; Microarry; Prognosis

Indexed keywords

ANXA2 PROTEIN, HUMAN; LIPOCORTIN 2; PHOSPHOPROTEIN PHOSPHATASE 2; PPP2CA PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CELL STRAIN HL 60; DNA MICROARRAY; DOWN REGULATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; PROGNOSIS; PROMYELOCYTIC LEUKEMIA; TUMOR CELL LINE; UPREGULATION;

ANNEXIN A2; CELL LINE, TUMOR; DOWN-REGULATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HL-60 CELLS; HUMANS; LEUKEMIA, MYELOID, ACUTE; LEUKEMIA, PROMYELOCYTIC, ACUTE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; PROTEIN PHOSPHATASE 2; UP-REGULATION;

EID: 38449096741     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.18.6.1395     Document Type: Article

References (28)

1. Lowenberg B, Downing JR and Burnett A: Acute myeloid leukemia. N Engl J Med 341: 1051-1062, 1999. (Pubitemid 29451802)
2. Nguyen S, Leblanc T, Fenaux P, Witz F, Blaise D, Pigneux A, Thomas X, Rigal HF, Lioure B, Auvrignon A, Fiere D, Reiffers J, Castaigne S, Leverger G, Harousseau JL, Socie G and Dombret H: A white blood cell index as the main prognostic factor in t(8,21) acute myeloid leukemia (AML): a survey of 161 cases from the French AML Intergroup. Blood 99: 3517-3523, 2000. (Pubitemid 34534517)
3. Alon U, Barkai N, Notterman DA, Gish K, Ybarra S, Mack D and Levine AJ: Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays. Proc Natl Acad Sci USA 96: 6745-6750, 1999. (Pubitemid 29274954)
4. Kiyoi H, Naoe T and Nakano Y: Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia. Blood 93: 3074-3080, 1999. (Pubitemid 29200800)
5. Kottaridis PD, Gale RE and Frew ME: The presence of an FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to the cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials. Blood 98: 1752-1759, 2001.
6. Hasle H, Clemmensen IH and Mikkelsen M: Risks of leukemia and solid tumors in individuals with Down's syndrome. Lancet 355: 165-169, 2000. (Pubitemid 30068214)
7. Leith CP, Kopecky KJ and Chen IM: Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1 and LRP in acute myeloid leukemia: a Southwest Oncology Group Study. Blood 94: 1086-1099, 1999. (Pubitemid 29361842)
8. Steinbach D, Sell W, Voigt A, Hermann J, Zintl F and Sauerbrey A: BCRP gene expression is associated with a poor response to remission induction therapy in childhood acute myeloid leukemia. Leukemia 16: 1443-1447, 2002.
9. Campos L, Rouault JP and Sabido O: High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy. Blood 81: 3091-3096, 1993. (Pubitemid 23162130)
10. Kohler T, Schill C and Deininger MW: High Bad and Bax mRNA expression correlate with a negative outcome in acute myeloid leukemia (AML). Leukemia 16: 22-29, 2002. (Pubitemid 34105595)
11. Avdi NJ, Malcolm KC, Nick JA and Worthen GS: A role for protein phosphatase-2A in p38 mitogen-activated protein kinase-mediated regulation of the c-Jun NH(2)-terminal kinase pathway in human neutrophils. J Biol Chem 277: 40687-40696, 2002. (Pubitemid 35215650)
12. Clancy JL, Henderson MJ, Russell AJ, Anderson DW, Bova RJ, Campbell IG, Choong DY, Macdonald GA, Mann GJ, Nolan T, Brady G, Olopade OI, Woollatt E, Davies MJ, Segara D, Hacker NF, Henshall SM, Sutherland RL and Watts CK: EDD, the human orthologue of the hyperplastic discs tumor suppressor gene, is amplified and overexpressed in cancer. Oncogene 22: 5070-5081, 2003. (Pubitemid 37026405)
13. Duggan DJ, Bittner M, Chen Y, Meltzer P and Trent JM: Expression profiling using cDNA microarray. Nat Genet 21: 10-14, 1999. (Pubitemid 29031485)
14. Grimwade D, Walker H and Oliver F: The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial: the Medical Research Council Adult and Children's Leukemia Working Parties. Blood 92: 2322-2333, 1998. (Pubitemid 28452973)
15. Steudel C, Wermke M, Schaich M, Schakel U, Illmer T, Ehninger G and Thiede C: Comparative analysis of MLL partial tandem duplication and FLT3 internal tandem duplication mutations in 956 adult patients with acute myeloid leukemia. Genes Chromosome Cancer 37: 237-251, 2003. (Pubitemid 36667562)
16. Thiede C, Steudel C and Mohr B: Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis. Blood 99: 4326-4335, 2002. (Pubitemid 34627197)
17. Armstrong SA, Staunton JE, Silverman LB, Pieters R, Boer ML, Minden MD, Sallan SE, Lander ES, Golub TR and Korsmeyer SJ: MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nat Genet 30: 41-47, 2002.
18. Qian XJ and Lin MF: Experimental study of the enhancement effect of aminopeptidase N inhibitor ubenimex on the differentiation induction activity of all-trans-retinoic acid in acute promyelocytic leukemia cells and its mechanism. Zhonghua Xue Ye Xue Za Zhi 7: 445-448, 2006.
19. Zhang QH, Ye M, Wu XY, Ren SX, Zhao M, Zhao CJ, Fu G, Shen Y, Fan HY, Lu G, Zhong M, Xu XR, Han ZG, Zhang JW, Tao J, Huang QH, Zhou J, Hu GX, Gu J, Chen SJ and Chen Z: Cloning and functional analysis of cDNAs with open reading frames for 300 previously undefined genes expressed in CD34+ hematopoietic stem/progenitor cells. Genome Res 10: 1546-1560, 2000.
20. Lin GY, Paterson RG, Richardson CD and Lamb RA: The V protein of the paramyxovirus SV5 interacts with damage-specific DNA binding protein. Virology 249: 189-200, 1998. (Pubitemid 28430920)
21. Kim SH, Shim KS and Lubec G: Human brain nascent polypeptide-associated complex alpha subunit is decreased in patients with Alzheimer' s disease and Down syndrome. J Investig Med 50: 293-301, 2002. (Pubitemid 34734230)
22. Yang XH and Huang S: PFM1 (PRDM4), a new member of the PR-domain family, maps to a tumor suppressor locus on human chromosome 12q23-q24.1. Genomics 61: 319-325, 1999.
23. Yang XF, Wu CJ, McLaughlin S, Chillemi A, Wang KS, Canning C, Alyea EP, Kantoff P, Soiffer RJ, Dranoff G and Ritz J: CML66, a broadly immunogenic tumor antigen, elicits a humoral immune response associated with remission of chronic myelogenous leukemia. Proc Natl Acad Sci USA 98: 7492-7497, 2001. (Pubitemid 32567976)
24. Henderson MJ, Russell AJ, Hird S, Munoz M, Clancy JL, Lehrbach GM, Calanni ST, Jans DA, Sutherland RL and Watts CK: EDD, the human hyperplastic discs protein, has a role in progesterone receptor coactivation and potential involvement in DNA damage response. J Biol Chem 277: 26468-26478, 2002. (Pubitemid 34967142)
25. Ofek P, Ben-Meir D, Kariv-Inbal Z, Oren M and Lavi S: Cell cycle regulation and p53 activation by protein phosphatase 2C alpha. J Biol Chem 278: 14299-14305, 2003. (Pubitemid 36799979)
26. Ruvolo PP, Clark W, Mumby M, Gao F and May WS: A functional role for the B56 alpha-subunit of protein phosphatase 2A in ceramide-mediated regulation of Bcl2 phosphorylation status and function. J Biol Chem 277: 22847-22852, 2002.
27. Sakamoto H, Mashima T, Kizaki A, Dan S, Hashimoto Y, Naito M and Tsuruo T: Glyoxalase I is involved in resistance of human leukemia cells to antitumor agent-induced apoptosis. Blood 95: 3214-3218, 2000. (Pubitemid 30321176)
28. Xia ZB, Anderson M, Diaz MO and Zeleznik-Le NJ: MLL repression domain interacts with histone deacetylases, the polycomb group proteins HPC2 and BMI-1 and the corepressor C-terminal-binding protein. Proc Natl Acad Sci USA 100: 8342-8347, 2003. (Pubitemid 36842547)